Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 5, 2002, Pages 281-289

  Crippa, Fulvio ^a   Holmberg, Leona ^a   Carter, Rachel A ^a   Hooper, Heather ^a   Marr, Kieren A ^a   Bensinger, William ^a   Chauncey, Thomas ^a   Corey, Lawrence ^a   Boeckh, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Autologous; CD34 selection; Infections; PBSC transplantation

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CD19 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; DAPSONE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; MYELOABLATIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER; CELL SELECTION; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOSIS; OPPORTUNISTIC INFECTION; PARAINFLUENZA VIRUS; PERIPHERAL BLOOD STEM CELL; RISK ASSESSMENT; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WHOLE BODY RADIATION;

EID: 0036273360     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm12064366     Document Type: Article

References (27)

1. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on Autologous Transplantation in Multiple Myeloma
2. High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
3. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: Comparison of autologous bone marrow and peripheral blood stem cells
4. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
5. Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients
6. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation
7. Selection and transplantation of autologous CD34+ B-lineage negative cells in advanced-phase multiple myeloma patients: A pilot study
8. Immune reconstitution after transplantation of autologous peripheral CD34+ cells: Analysis of predictive factors and comparison with unselected progenitor transplants
9. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors
10. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation
11. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
12. Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation
13. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial
14. Virologic characteristics of subclinical and symptomatic genital herpes infections
15. Infection with varicella-zoster virus after marrow transplantation
16. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
17. Neutropenic enterocolitis: Spectrum of the disease and comparison of definite and possible cases
18. Increased transplant-related mortality following high-dose sequential chemotherapy and autologous hematopoietic cell transplantation (AHCT) using the Ceprate SC stem cell concentration system for multiple myeloma
19. High incidence of symptomatic cytomegalovirus infection in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation
20. Immunologic reconstitution after hematopoietic stem cell transplantation
21. Parainfluenza virus respiratory infection after bone marrow transplantation
22. Parainfluenza infection after hematopoietic stem cell transplantation: Risk factors, response to antiviral therapy, and effect of transplant outcome
23. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention
24. Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: No evidence of increased incidence based on polymerase-chain-reaction monitoring
25. Increased incidence of cytomegalovirus infection and disease after autologous CD34-selected PBSC transplantation [reply]
26. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma
27. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants